Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shigyakusan for IBS and MUPS
NCT02653937Completed
- Sponsor
- Nakatani Clinic
- Start
- Mar 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of si ni san in irritable bowel syndrome (IBS) and somatoform disorders, sponsored by Nakatani Clinic. Primary endpoint: Number of participants who were suffered from IBS or MUPS, prescribed shigyakusan and improved at 2 years. Started Mar 2013; status: completed.
02
Drugs
si ni san
03
Conditions
irritable bowel syndrome (IBS)somatoform disorders
Beyond the preview
Go deeper on NCT02653937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653937.